David Joseph

President at XeroThera

David Joseph is the President of XeroThera, a company specializing in biomaterials and medical technologies aimed at improving healthcare outcomes. He joined XeroThera in January 2023, bringing with him over forty years of experience in healthcare and life sciences management.1 2

Professional Background

Entrepreneurial Experience: Joseph has co-founded and served as CEO for five companies within the medical technology and biopharmaceutical sectors, including notable roles at Avisa Pharma, Othera Pharmaceuticals, and Orthovita Inc.. His leadership at Orthovita culminated in the company's acquisition by Stryker Corporation in 2011.1 2
Previous Roles: His career includes significant positions such as:
- President & CEO at Avisa Pharma Inc. (2010 - Present)
- Chairman and CEO of Othera Pharmaceuticals (2001 - 2009)
- President and CEO of Orthovita (1993 - 2000)
- Co-Founder and President of Surgical Laser Technologies (1985 - 1992) and SITE Microsurgical Systems (1980 - 1985) which was acquired by Johnson & Johnson.1 2 3

Education

David Joseph holds a Master of Business Administration (M.B.A.) in Business and Health Care Administration from Xavier University, which he attended from 1964 to 1966.1 2

Recognition

He received the Raymond Rafferty Entrepreneurial Excellence Award from the Greater Philadelphia Venture Group in May 2005, acknowledging his contributions to venture-backed companies and his influence in the medical technology field.1 2

In summary, David Joseph's extensive background in healthcare entrepreneurship and management positions him as a significant figure in advancing XeroThera's goals in drug delivery and tissue engineering technologies.